Skip to content
Austrian Science Fund (FWF) logo

Master’s Thesis Position

Austrian Science Fund (FWF) · Research & science

Summary

This Master's thesis position focuses on non-genetic mechanisms of breast cancer cell adaptation to therapy, specifically investigating transcriptional heterogeneity and its role in developing resistance to endocrine therapy. The project involves establishing reporter cell lines to measure this heterogeneity and analyzing how drug treatment impacts it using various molecular and imaging techniques.

Key facts

Status
Available
Location
Vienna
Contract
Internship
Contract duration
12 months
Work arrangement
On-site
Start date
January 2027
Level
Entry
Education
Master's
Apply by
2026-12-31
Languages (required)

Languages (a plus)

  • English
Required skills
  • mammalian cell culture
  • molecular biology techniques
  • lentiviral work
  • R
  • Python
  • flow cytometry
  • CRISPRi
  • imaging
  • cell sorting
  • single cell RNA-seq
Benefits
  • Close supervision and hands-on training
Pay (estimated, unofficial)
~€35k–45k/yrRough guide for a full-time post; the employer named no amount How is this calculated?

Full description

Master’s Thesis Position

The Laboratory of Iros Barozzi at the Center for Cancer Research of the Medical University of Vienna is offering a Master thesis position of 6 to 12 months, starting in January 2027. The thesis focuses on non-genetic mechanisms that allow breast cancer cells to slowly adapt to therapy.

Most patients with estrogen-receptor positive (ER+) breast cancer respond well to endocrine therapy, yet a substantial fraction eventually relapses with resistant disease. Acquired genetic alterations explain only part of this, with much of the adaptations happening without any new mutation.

Genes are transcribed in stochastic bursts rather than continuously, so even genetically identical tumor cells differ in their gene expression at any given moment, and this transcriptional heterogeneity is thought to let a subset of cells tolerate treatment long enough for stable resistance to emerge.

Our overarching objective is to define the regulatory layer that governs this variability and to assess its potential as a therapeutic vulnerability.

Thesis Focus

The primary focus of this thesis project will be to establish fluorescent reporter cell lines for measuring transcriptional heterogeneity in ER+ breast cancer. The goal will be to determine how drug treatment affects this heterogeneity. This will be assessed by flow cytometry, various imaging techniques and single-cell RNA sequencing to address questions such as:

  • Which transcriptional and epigenetic regulators control transcriptional heterogeneity?
  • Does endocrine therapy change the degree of variability between cells?
  • Are more variable cells more likely to survive treatment? Requirements
  • Strong practical experience in mammalian cell culture and basic molecular biology techniques is required
  • Experience with lentiviral work is desirable
  • Basic coding proficiency in either R or Python is desirable
  • Good communication skills in English, ability to work in a team, and efficient organizational skills We offer
  • A highly dynamic and multidisciplinary research environment
  • Close supervision and hands-on training
  • Methods include flow cytometry, CRISPRi, imaging, cell sorting and single cell RNA-seq
  • Starting date: January 2027
  • Duration: 6 to 12 months Contact

For additional information about the research project and the position please contact: jonatan.kendler(at)meduniwien.ac.at

To apply for this position, please send your CV and a cover letter to: jonatan.kendler(at)meduniwien.ac.at

Fachgebiet

Cancer Research

Arbeitgeber

Iros Barozzi, Ass.-Prof. PhD

Arbeitsstätte

Center for Cancer Research, Medical University of Vienna

Antrittsdatum

01.01.2027

Bewerbungsfrist

31.12.2026

Kontakt

Jonatan Kendler jonatan.kendler(at)meduniwien.ac.at

Apply on the company site